
|Articles|September 16, 2002
Are antirejection drugs on the endangered list?
Transplant patients may one day be completely free from grueling regimens of immunosuppressive drugs, according to researchers from India, Stanford University, and the University of Pittsburgh. The investigators presented findings from three studies at the recent 19th International Congress of The Transplantation Society, which was held in Miami, Fla.
Advertisement
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Lower Baseline BMI Predicts Weight Loss At 6 Months With Liraglutide
2
Providers, Patients Show Favorable Perception of Remdesivir During COVID-19 Pandemic
3
PCV21 Shows Cost Effectiveness Compared With PCV15, PCV13, and PPSV23
4


























































































































































